These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 30100209

  • 1. Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor.
    Katz RB, Toprak M, Wilkinson ST, Sanacora G, Ostroff R.
    Gen Hosp Psychiatry; 2018; 54():62-64. PubMed ID: 30100209
    [No Abstract] [Full Text] [Related]

  • 2. The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises.
    Wang JCC, Swainson J.
    J Clin Psychopharmacol; 2020; 40(5):515-517. PubMed ID: 32740556
    [No Abstract] [Full Text] [Related]

  • 3. Ketamine and Monoamine Oxidase Inhibitor Combination: Utility, Safety, Efficacy?
    Bottemanne H, Bonnard E, Claret A, Petit AC, Gaillard R, Fossati P.
    J Clin Psychopharmacol; 2020; 40(6):636-638. PubMed ID: 33009225
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study.
    Ludwig VM, Sauer C, Young AH, Rucker J, Bauer M, Findeis H, Ritter P.
    CNS Drugs; 2021 Aug; 35(8):881-892. PubMed ID: 34283390
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study.
    Vidal S, Gex-Fabry M, Bancila V, Michalopoulos G, Warrot D, Jermann F, Dayer A, Sterpenich V, Schwartz S, Vutskits L, Khan N, Aubry JM, Kosel M.
    J Clin Psychopharmacol; 2018 Dec; 38(6):590-597. PubMed ID: 30346333
    [Abstract] [Full Text] [Related]

  • 6. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH, Volkers AC, van den Broek WW, Bruijn JA.
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract] [Full Text] [Related]

  • 7. Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder.
    Adams TG, Bloch MH, Pittenger C.
    J Clin Psychopharmacol; 2017 Apr; 37(2):269-271. PubMed ID: 28121735
    [No Abstract] [Full Text] [Related]

  • 8. Psychopharmacology column: why choose selegiline transdermal system for refractory depression?
    Tobin M.
    Issues Ment Health Nurs; 2007 Feb; 28(2):223-8. PubMed ID: 17365170
    [No Abstract] [Full Text] [Related]

  • 9. The role of monoamine oxidase inhibitors in depression treatment guidelines.
    Thase ME.
    J Clin Psychiatry; 2012 Feb; 73 Suppl 1():10-6. PubMed ID: 22951237
    [Abstract] [Full Text] [Related]

  • 10. Esketamine nasal spray (Spravato) for treatment-resistant depression.
    Med Lett Drugs Ther; 2019 Apr 08; 61(1569):54-57. PubMed ID: 31169797
    [No Abstract] [Full Text] [Related]

  • 11. Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases.
    Bartova L, Vogl SE, Stamenkovic M, Praschak-Rieder N, Naderi-Heiden A, Kasper S, Willeit M.
    Eur Neuropsychopharmacol; 2015 Nov 08; 25(11):2183-4. PubMed ID: 26302763
    [Abstract] [Full Text] [Related]

  • 12. Discussion: a fresh look at monoamine oxidase inhibitors for depression.
    Cohen LJ, Sclar DA, Culpepper L, Flockhart DA, Hirschfeld RM, Thase ME, VanDenBerg CM.
    J Clin Psychiatry; 2012 Nov 08; 73 Suppl 1():42-5. PubMed ID: 22951242
    [No Abstract] [Full Text] [Related]

  • 13. Repeated ketamine injections in synergy with antidepressants for treating refractory depression: A case showing 6-month improvement.
    Wang M, Xiong Z, Su B, Wang L, Li Z, Yang Y, Fang J, Li Z.
    J Clin Pharm Ther; 2020 Feb 08; 45(1):199-203. PubMed ID: 31468568
    [Abstract] [Full Text] [Related]

  • 14. Intravenous Ketamine Relieves Pain and Depression After Traumatic Suicide Attempts: A Case Series.
    Mischel N, Bjerre-Real C, Komisar J, Ginsberg B, Szabo ST, PreudʼHomme X.
    J Clin Psychopharmacol; 2018 Apr 08; 38(2):149-150. PubMed ID: 29424806
    [No Abstract] [Full Text] [Related]

  • 15. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT.
    J Am Geriatr Soc; 2007 Nov 08; 55(11):1890. PubMed ID: 17979910
    [No Abstract] [Full Text] [Related]

  • 16. Monoamine oxidase inhibitors revisited.
    Wells DG, Bjorksten AR.
    Can J Anaesth; 1989 Jan 08; 36(1):64-74. PubMed ID: 2563341
    [No Abstract] [Full Text] [Related]

  • 17. Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions.
    Andrade C.
    J Clin Psychiatry; 2017 Jul 08; 78(7):e858-e861. PubMed ID: 28858450
    [Abstract] [Full Text] [Related]

  • 18. Ketamine for Depression, 3: Does Chirality Matter?
    Andrade C.
    J Clin Psychiatry; 2017 Jun 08; 78(6):e674-e677. PubMed ID: 28682536
    [Abstract] [Full Text] [Related]

  • 19. Ketamine-induced affective switch in a patient with treatment-resistant depression.
    Banwari G, Desai P, Patidar P.
    Indian J Pharmacol; 2015 Jun 08; 47(4):454-5. PubMed ID: 26288483
    [Abstract] [Full Text] [Related]

  • 20. Esketamine for treatment-resistant depression.
    Drug Ther Bull; 2020 Dec 08; 58(12):183-188. PubMed ID: 33243929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.